By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News
Oct. 15--Johnson & Johnson posted a 20 percent rise in net earnings for the third quarter Tuesday, helped by sales from a new heart device and favorable currency exchange rates.
Overall sales at the diversified New Brunswick-based health-care giant rose to $10.5 billion for the quarter, despite declines in its biggest-selling product. Sales of the anemia treatment Procrit fell 8 percent to just more than $1 billion in the quarter because of competition from a new produc